Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapies Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The allergy immunotherapies market is forecast register a CAGR of more than 7% by 2023.


The latest trend gaining momentum in the market is the emerging drug development technologies. According to the report, one of the major drivers for this market is the increasing prevalence of various types of allergies. Further, the report states that one of the major factors hindering the growth of this market is the unknown pathogenesis.

The emerging drug development technologies is likely to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies.

The increasing prevalence of various types of allergies across the globe is driving the allergy immunotherapies market. The growing occurrence of allergy is generated by the factors such as increasing pollution and augmented consumption of tobacco products like cigarettes, which is likely to boost the global allergy immunotherapy market.

The Unknown pathogenesis of various allergies is the major challenge faced by the global allergy immunotherapies market. The unclear cause of allergy results in physicians misdiagnosing the allergen, and as a result the treatment prescribed is not as effective as it should be, and it often leads to adverse events.

With the presence of a considerable number of companies, this market appears to be fragmented. The current advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more effective immunotherapies for the treatment of various allergies. Several established allergy immunotherapy manufacturers are striving for their share of the global allergy immunotherapies market, and the new players must differentiate themselves to gain vital traction over their competitors.

Key Players

• ALK
• Allergy Therapeutics
• HAL Allergy
• Merck
• Stallergenes Greer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• SCIT - Market size and forecast 2018-2023
• SLIT - Market size and forecast 2018-2023
• Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• EMEA - Market size and forecast 2018-2023
• Americas - Market size and forecast 2018-2023
• APAC - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALK
• Allergy Therapeutics
• HAL Allergy
• Merck
• Stallergenes Greer

For more information about this report visit https://www.researchandmarkets.com/research/rbbqbq/allergy?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Allergy Drugs